Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Edition  2017: Volume 22/ Issue 20 Article 1
Back to Table of Contents
Download (pdf)

Eurosurveillance, Volume 22, Issue 20, 18 May 2017
Research article
Beauté, Cowan, Hiltunen-Back, Kløvstad, Velicko, and Spiteri: Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013

+ Author affiliations

Citation style for this article: Beauté J, Cowan S, Hiltunen-Back E, Kløvstad H, Velicko I, Spiteri G. Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013. Euro Surveill. 2017;22(20):pii=30537. DOI:

Received:05 August 2016; Accepted:23 September 2016


Gonorrhoea is a common sexually transmitted infection (STI). Although gonorrhoea can be asymptomatic, particularly in women and in pharyngeal and rectal infections, it is a major cause of urethritis in both men and women. In women, infection can lead to pelvic inflammatory disease, which may cause infertility [1].

The World Health Organization estimates that in 2012 there were over 78 million cases of gonorrhoea globally [2]. In 2013, 52,995 cases of gonorrhoea were reported in European Union (EU)/European Economic Area (EEA) countries (16.9 cases per 100,000 population) [3]. Of these, 2,701 (5.1%) were reported by Denmark, Finland, Norway and Sweden. Notification rate was close to the EU/EEA average in Denmark, Norway and Sweden (10–15 cases per 100,000 population) but lower in Finland (4.9). In these countries, most cases were reported among 25–34 year olds (960 cases; 36%) and among young adults aged 15–24 (908 cases; 34%). Men accounted for 75% of cases (2,012 cases) and 39% (1,050 cases) were reported among men who have sex with men (MSM). The number of reported cases has increased by 61% since 2009.

MSM are a key at-risk group for infection and accounted for 43% of gonorrhoea cases in the EU/EEA in 2013 [3]. The risk of transmission of gonorrhoea can be reduced by consistent and correct condom use during sex [4]. Apart from primary prevention and partner notification, effective treatment is the only option for control of gonorrhoea in the absence of an effective vaccine. European and national treatment guidelines are available [5]. An increasing number of Neisseria gonorrhoeae strains have been reported with reduced susceptibility to antimicrobials used for treatment [6].

The relation between travel and infectious diseases is of public health concern for two main reasons. First, travel can facilitate the international spread of diseases. Second, travel may be associated with an additional disease burden due to both different risk and exposure in the destination country compared with the country of origin. Such specific risk may justify targeted preventive measures such as vaccination, prophylaxis [7], or in the case of STIs, the provision of advice before departure and testing upon return.

The historical role of travellers in spreading STIs is well documented [8]. Travel is also a known risk factor for STIs for a number of reasons, including changes in sexual behaviour when travelling [8]. Thus, travel has been shown to remove social taboos and to increase the likelihood of casual sexual relationships [9]. Travel is also associated with low condom use and sex may be the main objective of the journey (sex tourism) [9]. Travellers might also have sex with populations with higher prevalence of STIs, such as sex workers, or they might be visiting countries with a high prevalence of STI and therefore increase their risk of infection [9]. In addition, the emergence of antibiotic-resistant strains of gonorrhoea has been linked to countries in south-east Asia and Japan, and therefore travellers might import such strains to Europe [10]. Similarly, the prevalence of strains resistant to antimicrobials might be higher in further countries/regions outside Europe and lead to importation of resistant strains [9].

Estimating the real risk of travel-associated STIs is challenging. Data, particularly from Europe, are limited, notably because of reporting biases, incompleteness of STI surveillance data [8] and difficulties in obtaining sound data on travel patterns [11]. Yet, with an increasing number of travellers, it is important to better document, prevent and control travel-associated STI. Indeed, over the past 20 years, global tourist departures have doubled to reach half a billion in 2013, and Europe accounts for half of them [12].

The objective of this study is to estimate the risk for gonorrhoea among travellers from four Nordic countries using surveillance and tourism denominator data and to identify at-risk travellers to help target interventions.


Gonorrhoea data

The epidemiological surveillance of gonorrhoea in Europe is carried out at the national level by EU/EEA countries’ public health institutes or similar bodies. At the European level, representatives from the countries form the European Network for STI Surveillance, which is coordinated by the European Centre for Disease Prevention and Control (ECDC). The network comprises all 28 EU countries, plus Iceland and Norway. Each year, all diagnosed cases meeting the EU case definition for gonorrhoea in the previous year are reported to The European Surveillance System (TESSy) database hosted by ECDC [13]. Cases are reported with a set of variables including age, sex, probable mode of transmission, country of birth, and probable country of infection. In addition, a separate and unlinked surveillance system, the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), collects epidemiological and antimicrobial resistance data on a subset of isolates from sentinel laboratories in participating Member States. Euro-GASP surveillance data were not analysed due to the very low completeness of reported epidemiological data on the probable country of infection.

For the purpose of this analysis, we included epidemiological surveillance data from four Nordic countries (Denmark, Finland, Norway and Sweden) for the years 2008−2013. These countries (total population 26 million) have surveillance systems with comprehensive coverage of the population and have reported continuously during the study period (i.e. at least one travel-associated case each year). In addition, Nordic countries share a number of similarities in their outbound tourism patterns, with trips more evenly distributed across the year [14], which support a pooled analysis. A travel-associated case of gonorrhoea was defined as one for which the reported probable country of infection differed from the reporting country. A foreign-born case was defined as a case with a country of birth different from the reporting country.

Tourism data

Tourism denominator data for 2008−2013 were obtained from the Statistical Office of the EU (Eurostat) [15]. We used the total number of nights spent by destination country. This included all tourism nights spent by EU/EEA residents aged 15 years or over, in a collective accommodation establishment or in private tourism accommodation for personal or professional purposes. In most countries, this information is collected through household surveys. Number of nights by sex and age was only available for Denmark. Since tourism nights were not available for all country-region combinations for all years, we calculated the mean of tourism nights for the available years over the study period. To obtain a denominator for the entire study period (6 years), the mean number of tourism nights was then multiplied by six.


Travel-associated cases of gonorrhoea were compared with non-travel-associated cases for main characteristics. Risk for travel-associated gonorrhoea was calculated by dividing the number of travel-associated cases by the number of nights spent in the destination country. For Denmark, risk was also calculated by sex and age group. For all countries, risk was additionally calculated by region of travel. We considered five main regions (Africa, the Americas, Asia, Europe and Oceania). We divided the Americas further into North America (including Greenland) and Central and South America (including Mexico). In Europe, we distinguished EU countries from other European countries (including Turkey).

Continuous variables were compared across strata by the Mann–Whitney U test. Categorical variables were compared using the chi-squared or Fisher exact tests.

To assess the association of different variables with travel-associated gonorrhoea, we performed a multivariable logistic regression using surveillance data and estimated adjusted odds ratios (OR) with their 95% confidence intervals (CI). We adjusted for sex, age, route of transmission, country of residence, origin and year.


During the 2008−2013 period, Denmark, Finland, Norway and Sweden reported 12,645 gonorrhoea cases, of which 11,407 (90.2%) had information on probable country of infection. (Table 1).

Table 1

Main characteristics of reported cases with gonorrhoea infection by probable travel status, Denmark, Finland, Norway and Sweden, 2008–2013 (n = 12,645)

Total Travel‑associated cases Non‑travel‑associated cases
Characteristic Number Number % Number %
Total 12,645 3,224 100 9,421 100
          Male 9,635 2,755 85.5 6,880 73.0
          Female 3,009 469 14.5 2,540 27.0
          Unknown 1 0 NA 1 NA
Age group (years)
          < 15 21 2 0.1 19 0.2
          15–24 4,438 780 24.2 3,658 38.8
          25–34 4,142 940 29.2 3,202 34.0
          35–44 2,293 730 22.6 1,563 16.6
          45–54 1,181 488 15.1 693 7.4
          55–64 430 202 6.3 228 2.4
          ≥ 65 139 82 2.5 57 0.6
          Unknown 1 NA NA 1 NA
          Heterosexual 7,149 2196 76.8 4,953 58.4
          MSM 4,143 652 22.8 3,491 41.2
          Other 46 10 0.3 36 0.4
          Unknown 1,307 366 NA 941 NA
Country of residence
          Denmark 3,445 365 11.3 3,080 32.7
          Finland 1,558 531 16.5 1,027 10.9
          Norway 2,299 790 24.5 1,509 16.0
          Sweden 5,343 1,538 47.7 3,805 40.4
          Native 4,824 939 84.8 3,885 94.9
          Foreign-born 376 168 15.2 208 5.1
          Unknown 7,445 2,117 NA 5,328 NA
          2008 1,632 460 14.3 1,172 12.4
          2009 1,683 461 14.3 1,222 13.0
          2010 1,991 568 17.6 1,423 15.1
          2011 2,109 575 17.8 1,534 16.3
          2012 2,526 571 17.7 1,955 20.8
          2013 2,704 589 18.3 2,115 22.4

MSM: men who have sex with men; NA: not applicable.

Of the 12,645 reported cases, 3,224 (25.5%) were travel-associated. This proportion fluctuated between 27.3% and 28.5% from 2008 to 2011 and then dropped to 22.6% in 2012 and 21.8% in 2013. Over the period, the annual number of cases continuously increased from 1,632 in 2008 to 2,704 in 2013 (+ 65.7%). This increase was observed for both travel-associated and non-travel-associated cases, but the increase was more pronounced in non-travel-associated cases (+ 80.5% vs + 28.0%). Finland, Norway and Sweden had similar proportions of travel-associated cases (ca 30%) while only 10.6% of Danish cases were related to travel.


Of the 3,224 travel-associated cases, 2,755 (85.5%) were male, giving a male-to-female ratio of 5.9:1 (Table 1). Overall, the male-to-female ratio increased with age (1.8:1 below 25 years, 6.7:1 for the 25–34 years and > 15 above 35 years). Cases in males were more often travel-associated than cases in females (28.6% vs 15.6%, p < 0.01). The proportion of females reported with gonorrhoea infections increased over the study period from below 20% in 2008 to over 25% in 2011−2013. Similarly, the proportion of females among travel-associated cases increased from 10% in 2008 to 15–19% in 2011−2013. Travel-associated cases were older than non-travel-associated cases (median age at diagnosis 33 vs 27 years, respectively, p < 0.01). Median ages of both travel-associated and non-travel-associated cases were stable over the study period. The proportion of travel-associated cases increased with age from 17.5% below 25 years to 59.0% at 65 years and above. Of the 3,224 travel-associated cases, 1,722 (53.4%) were young adults below 35 years of age; among non-travel-associated cases, young adults accounted for 73.0% of cases. Information on country of origin was available in Denmark, Finland and Norway. Of the 5,200 cases with known country of origin, 376 (7.2%) were foreign-born. Foreign-born cases were more often travel-associated than native-born cases (15.2% vs 5.1%, p < 0.01).


Of the 2,858 (88.6%) travel-associated cases with known probable route of transmission, 2,196 (76.8%) were reported as heterosexual transmission, 652 (22.8%) were due to sex between men, and 10 (0.3%) were through other routes of transmission (Table 1). Of the 2,432 travel-associated cases in males with known transmission status, 652 (26.8%) were MSM, ranging from 19.4% (58/299) in Denmark to 31.7% (230/725) in Norway. The proportion of travel-associated cases was higher in heterosexually transmitted cases compared with MSM (30.7% vs 15.7%, p < 0.01) and this was observed in all countries. Between 2008 and 2013, the annual number of travel-associated cases with heterosexual transmission fluctuated between 309 (2009) and 425 cases (2011). During the same period, the number of travel-associated cases with MSM transmission continuously increased from 53 in 2008 to 188 cases in 2013. Conversely, the number of travel-associated cases with unknown route of transmission continuously decreased from 84 in 2008 to 19 in 2013. Thus, the proportion of cases with MSM transmission among travel-associated cases with known transmission status increased from 14.1% in 2008 to 33.0% in 2013.

Risk by country of residence, sex, age and destination

During 2008−2013, residents from Denmark, Finland, Norway and Sweden spent ca 1,320 million nights abroad (Table 2).

Table 2

Number of travel-associated cases of gonorrhoea, number of nights spent and risk by travel region, Denmark, Finland, Norway and Sweden, 2008−2013 (n = 3,224)

Travel‑associated cases              Tourism nights             
(estimate 2008–2013)
(cases/million nights)
Region Number %
Total (all regions) 3,224 100 1,319,713,232 2.4
Africa 169 5.2 52,777,817 3.2
The Americas
          North America 120 3.7 94,163,334 1.3
          Central and South America 116 3.6 38,425,724 3.0
Asia 1,553 48.2 165,075,367 9.4
          EU 27 1,044 32.4 788,962,938 1.3
          Other European countries 196 6.1 155,107,899 1.3
Oceania 26 0.8 25,200,155 1.0

EU: European Union.

While the number of travel associated cases are aggregated for the period 2008–2013, tourism nights were not available for all country-region combinations for all years. The denominator for the risk calculation is therefore the mean of tourism nights for the available years multiplied by six.

The most visited regions were the EU (59.8% of all nights spent), Asia (12.5%) and North America (7.1%). The overall risk for travel-associated gonorrhoea was 2.4 cases per million nights spent in outbound destinations (Table 2). The highest risk was found in Swedish travellers (3.1 cases per million nights) followed by Norwegian, Finnish and Danish travellers with 2.5, 2.2, and 1.2 cases per million nights, respectively. In Denmark, where tourism data were available by sex and age group, a higher risk for travel-associated gonorrhoea was observed in males compared with females (1.9 vs 0.3 cases per million nights, respectively) and among persons aged below 45 years, peaking at 2.2 cases per million nights for people aged 25–34 years (Table 3).

Table 3

Number of travel-associated cases of gonorrhoea, number of nights spent and risk by sex and age, Denmark, 2008−2013 (n = 365)

Travel-associated cases Tourism nights Risk
(cases/million nights)
Characteristic Number % Number
(mean 2012−2013)
Total 365 100 53,427,522 1.1
          Male 315 86.3 27,881,556 1.9
          Female 50 13.7 25,545,965 0.3
Age group (years)
          < 15 0 NA NA NA
          15–24 86 23.6 8,659,638 1.7
          25–34 116 31.8 8,929,735 2.2
          35–44 84 23.0 8,653,369 1.6
          45–54 50 13.7 11,391,493 0.7
          55–64 20 5.5 8,526,496 0.4
          ≥ 65 9 2.5 7,266,792 0.2

NA: not applicable.

While the number of travel associated cases are aggregated for the period 2008–2013, tourism nights were only available for 2012−2013 by age and sex. The denominator for the risk calculation is therefore the mean of tourism nights for the available years multiplied by six.

Of the 3,224 travel-associated cases, 2,793 (86.6%) had acquired their infection either in Asia or Europe (Table 3). From December to July, Asia was the top destination for travel-associated gonorrhoea (53.4% of all travel-associated cases) peaking in January when Asia accounted for 60.6% of all travel-associated cases. From August to November, the top destination was Europe (48.6%) although the proportion of cases who had travelled to Asia remained substantial (36.5%). Monthly distributions of cases associated with travel to Africa, the Americas or Oceania did not show any obvious seasonal pattern. The highest risk was associated with travel to Asia with 9.4 cases per million nights. Travel to Africa and Central and South America was associated with a risk of ca 3 cases per million nights. Almost a third of all travel-associated cases were associated with a stay in Thailand, and the three destinations with the highest numbers of cases (Thailand, the Philippines and Spain) accounted for nearly half of all cases (Table 4).

Table 4

Top destinations for travel-associated gonorrhoea cases, Denmark, Finland, Norway and Sweden, 2008−2013

Travel-associated cases
Rank Destination country Number %
1 Thailand 1,006 31.2
2 Philippines 258 8.0
3 Spain 229 7.1
4 Germany 199 6.2
5 Denmark 95 2.9
6 United Kingdom 93 2.9
7 United States 71 2.2
8 Turkey 67 2.1
9 Russia 65 2.0
10 Morocco 63 2.0
11 China 56 1.7
12 Sweden 51 1.6
13 France 50 1.6
14 Greece 47 1.5
15 Greenland 45 1.4
16 Indonesia 45 1.4
17 Brazil 42 1.3
18 Poland 37 1.1
19 Italy 29 0.9
20 Pakistan 27 0.8
Other 649 20.1
Total 3,224 100

Most cases with a probable country of infection in south-east Asia were reported with heterosexual transmission (98.3% for the Philippines and 95.9% for Thailand). Conversely, higher proportions of cases with MSM transmission were reported for top European destinations: in decreasing order, Germany (63.8%), the United Kingdom (59.1%), Spain (55.4%) and Denmark (55.2%). A comparable proportion of cases with MSM transmission was observed in people who travelled to the United States (55.9%). Top destinations for travel-associated gonorrhoea were very similar across all four Nordic countries with the exception of Greenland and Russia, which accounted for 12.3% and 9.0% of infections among Danish and Finnish travellers, respectively (Table 5).

Table 5

Top destinations for travel-associated gonorrhoea cases by country of residence, Denmark, Finland, Norway and Sweden, 2008−2013

Denmark Finland Norway Sweden
Destination country Travel‑associated cases Destination country Travel‑associated cases Destination country Travel‑associated cases Destination country Travel‑associated cases
Number % Number % Number % Number %
1 Thailand 91 24.9 Thailand 217 40.9 Thailand 229 29.0 Thailand 469 30.5
2 Greenland 45 12.3 Russia 48 9.0 Philippines 77 9.7 Spain 119 7.7
3 Philippines 35 9.6 Philippines 40 7.5 Spain 75 9.5 Philippines 106 6.9
4 Germany 14 3.8 Spain 24 4.5 Germany 62 7.8 Germany 102 6.6
5 Spain 11 3.0 Germany 21 4.0 Sweden 31 3.9 Denmark 82 5.3
Other 169 46.3 Other 181 34.1 Other 316 40.0 Other 660 42.9
Total 365 100 Total 531 100 Total 790 100 Total 1,538 100

The proportion of travel-associated cases with a probable infection in Thailand decreased from ca 40% in 2008−2009 to 26.0% in 2013. Of the 376 foreign-born travel-associated cases, 154 (41.0%) travelled to their country of birth.

Multivariable analysis

When adjusting for potential confounders, males were nearly three times more likely to have acquired their infection abroad compared with females (OR: 2.96, 95% CI: 2.62–3.34) (Table 6).

Table 6

Adjusted predictors of travel-associated gonorrhoea cases, Denmark, Finland, Norway and Sweden, 2008−2013 (n = 12,643)

Risk factor OR 95% CI p value Cases exposed
          Female 1 (Ref) NA NA 23.8
          Male 2.96 2.62–3.34 < 0.01 76.2
Age group (years)
          < 25 1 (Ref) NA NA 35.3
          25–34 1.40 1.24–1.57 < 0.01 32.8
          35–44 2.38 2.09–2.71 < 0.01 18.1
          45–54 3.51 3.01–4.10 < 0.01 9.3
          55–64 4.36 3.47–5.49 < 0.01 3.4
          ≥ 65 6.04 4.12–8.84 < 0.01 1.1
          MSM 1 (Ref) NA NA 32.8
          Heterosexual 4.08 3.66–4.56 < 0.01 56.5
          Other 2.15 1.03–4.47 0.04 0.4
          Unknown 1.85 1.50–2.28 < 0.01 10.3
Country of residence
          Sweden 1 (Ref) NA NA 42.3
          Denmark 0.22 0.18–0.26 < 0.01 27.2
          Finland 1.37 1.15–1.62 < 0.01 12.3
          Norway 1.48 1.26–1.73 < 0.01 18.2
          Native 1 (Ref) NA NA 38.1
          Foreign-born 8.34 6.46–10.76 < 0.01 3.0
          Unknown 1.28 1.10–1.49 < 0.01 58.9
          2008 1 (Ref) NA NA 12.9
          2009 1.04 0.88–1.23 0.65 13.3
          2010 1.09 0.93–1.29 0.27 15.8
          2011 0.98 0.83–1.15 0.81 16.7
          2012 0.81 0.69–0.95 0.01 20.0
          2013 0.83 0.71–0.98 0.03 21.4

CI: confidence interval; MSM: men who have sex with men; NA: not applicable; OR: odds ratio; Ref: reference value.

The risk of travel-associated gonorrhoea increased with age. Heterosexual transmission of gonorrhoea was four times more likely to be travel-associated compared with MSM (OR: 4.08, 95% CI: 3.66–4.56). Compared with natives, foreign-born cases were eight times more likely to be travel-associated (OR: 8.34, 95% CI: 6.46–10.76). With 2008 as reference, infections acquired in 2012 and 2013 were less likely to be travel-associated.


Principal findings

Surveillance data from four Nordic countries suggested that at least 25% of gonorrhoea infections were related to travel, a proportion that slightly decreased over the study period. Half of these cases had a travel history in Asia, a continent that accounted for fewer than 15% of the nights spent abroad by the residents of these countries. Most of the travel-associated cases were observed among persons below 35 years of age. The Danish cases for which denominator information was available suggested that the highest risk for travel-associated gonorrhoea was among the 25–34 year-olds. Danish data also showed that the risk for travel-associated gonorrhoea in men is six times higher compared with women. This is consistent with the finding that younger people and men are more likely to report having a new sex partner while travelling [16]; younger people are also more likely to have a higher number of sex partners in general [17], which is a risk factor for having a new sex partner while overseas [16].

Although the reported number of cases of gonorrhoea decreased with age, the proportion of cases of gonorrhoea which were travel-related increased with age, with a peak of 59% among those aged 65 years or over; almost all of these cases were reported among heterosexual men. Very few cases of travel-related gonorrhoea were diagnosed among people aged 65 years and above and therefore older persons are at lower risk of acquiring gonorrhoea per million bed nights.

During the study period, the number of gonorrhoea and travel-associated gonorrhoea cases increased in all four countries, but the proportion of travel-associated cases decreased most recently in 2012−2013. Overall, this rise in reported cases has been mainly due to increasing numbers of cases among MSM, regardless of travel status [3], which is partly linked to continuing high-risk behaviour in this subpopulation [18], partly to increased testing and use of more sensitive tests such nucleic acid amplification tests [19]. The larger increase among locally acquired cases compared with travel-associated cases is likely to reflect the larger proportion of MSM among locally acquired cases. The increasing number of travel-associated cases with MSM transmission over the study period cannot be explained solely by improved data completeness for transmission status, but should be considered in the context of increasing reports of cases among MSM overall during this time period [3].

A disproportionate number of cases were associated with travel to Thailand and the Philippines. Although some of these cases are likely to be acquired through contact with sex workers, many travellers, particularly backpackers, often find sexual partners among other travellers. The risk of new partner acquisition and overall risk of unsafe sex among backpackers in Thailand has been found to be associated with male gender and longer trip length [20]. Backpackers are also less likely to use condoms when having sex with travel partners compared than with commercial sex workers [21]. Thailand is reported to be the foreign country where the largest number of Swedish males contract HIV and many Swedish men have sex with commercial sex workers while on holiday there, leading to risk of transmission of STI also from the local population [22].

South-east Asian countries are reported to have high levels of multidrug-resistant N. gonorrhoeae [23]. Information on the laboratory test used to confirm gonorrhoea is not available within the European surveillance system. This makes it difficult to know how often culture and subsequent susceptibility testing were performed among travel-associated cases. Considering the current concerns on antimicrobial-resistant gonorrhoea in Europe and globally [24], monitoring susceptibility of strains acquired during travel is important.

Over half of gonorrhoea infections acquired in the top European destinations were in MSM. This reflects the high prevalence of MSM having sex abroad, reported to be 25% in the previous 12 months from the European Men-Who-Have-Sex-With-Men Internet Survey (EMIS), and the low proportion of condom use during anal intercourse while abroad [25]. The top destinations for sex abroad reported in EMIS were also Spain and Germany, as in our study. Barcelona and Berlin are both extremely popular sex tourism hotspots in Europe for MSM.

Foreign-born cases were more likely to be travel-associated compared with natives. Approximately 40% of travel-associated foreign-born cases travelled to their country of birth, probably visiting friends or relatives (VFR). VFR travellers are a well-identified risk group for travel-associated illness although the definition may mask a more complex reality [26].

Strengths and weaknesses of the study

The study is based on a relatively homogeneous population in the Nordic European countries. A substantial proportion of Nordic residents travel abroad and this makes the Nordic population very suitable for estimating risk of travel-associated conditions. The surveillance systems for STIs in these countries have been stable during this time, with good case ascertainment and availability of diagnostics. Unfortunately it was not possible to incorporate analysis of Euro-GASP data due to the low completeness of the relevant variables. Improving the completeness of these variables in Euro-GASP should be a priority to allow for better monitoring of the resistance patterns of strains imported into Europe.

The travel behaviour across the included countries is also rather similar: residents of Nordic countries tend to travel to warmer countries during the darkest and coldest months of the year. Travel tourism data were collected mostly via household survey, a method which is prone to memory bias. However, the number of nights spent by destination was fairly stable over the study period suggesting that these data were reliable. Our decision to average the number of nights spent for the study period may have masked annual variations, especially for destinations with fewer nights spent, such as Africa or Oceania. For such destinations the estimated risk may be less accurate.

Unfortunately, tourism data were not available by age group and sex for Finland, Norway and Sweden, limiting enhanced analysis of the data. In Denmark where tourism data were available by age group, there was little variation over 2012−2013. Information on the purpose of travel was not available for cases. Therefore, we were not able to differentiate leisure tourism from business travel or family visits.

Comparison with other studies

The data presented in this paper are consistent with data reported by Steffen et al. who estimated a risk of travel-associated gonorrhoea of 0.06% per month of stay in developing countries [27]. Our findings indicate the highest risk was associated with travel to Asia with 9.4 cases/million nights, which would correspond to an incidence rate of 0.03% per month.

The high proportion of travel-associated cases in older age groups has previously been reported in Sweden where more than 50% of gonorrhoea cases aged 35 years or over were infected abroad during 2007−2011, compared with 20% to 25% for persons below 35 years of age [28]. The Swedish study found that women and MSM were more frequently infected in Sweden than heterosexually infected men. A recent systematic review of casual sex and foreign travel found that people engaging in casual sex while abroad are more likely to be young and males [29].

Possible explanations and implications for clinicians and policymakers

The results presented here highlight the role of young adults below 35 years of age in the epidemiology of gonorrhoea, including travel-associated gonorrhoea. International guidelines recommend specifically addressing STI during pre-travel consultations [7] but a recent systematic review underlined the low level of evidence on the impact of standard STI pre-travel advice on sexual behaviour [30]. The same review also found that motivational pre-travel STI interventions (described as ‘a directive, client-centred counselling style for eliciting behaviour change by helping clients to explore and resolve ambivalence’ [31]) were not superior to standard STI travel advice [30]. One cohort study identified in this review, however, did find that recall of reading STI information appeared to be related to more consistent condom use [30]. Since a large proportion of travellers do not seek advice in pre-travel consultations [32], other channels of information such as social media including dating apps could be explored. Young adults could be targeted with safe-sex messages related to travel when visiting STI or youth clinics: persons with a history of multiple sex partners and/or an STI are at risk of travel-associated casual sex [29]. The role of social media in targeting prevention messages needs to be considered and further investigated: research suggests that social media plays an increasing role as information sources for travellers [33,34]. Apart from social media, online resources are extensively used by all age groups for travel planning [34]. Targeted online prevention messages could be considered at peak travel periods together with research on their effectiveness.

Apart from the safe-sex message, young adults should be educated to know that a large proportion of gonorrhoea cases are asymptomatic and hence, after risky behaviour, testing is important irrespective of symptoms.

Finally, these data indicate that older males have a higher likelihood of having been infected abroad when presenting with a gonorrhoea infection. This should be taken in consideration by clinicians when treating these patients. Although they represent a lesser burden when compared with younger age groups, this population should not be forgotten by public health interventions.

Conflict of interest

None declared.

Authors’ contributions

JB and GS conceived and designed the study. JB, SC, EHB, HK, IV and GS contributed to the data collection. JB ran the analysis. JB and GS drafted the manuscript. All authors contributed to revising the manuscript, providing substantial intellectual input.


  1. Holmes K, Sparling P, Stamm W, Piot P, Wasserheit J, Corey L, et al. Sexually Transmitted Diseases, Fourth Edition. 4 edition. New York: McGraw-Hill Professional; 2007. 2192 p.

  2. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N,  et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015;10(12):e0143304. DOI: 10.1371/journal.pone.0143304 PMID: 26646541

  3. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 2013. Stockholm: ECDC; 2015. Available from:

  4. Clutterbuck DJ, Flowers P, Barber T, Wilson H, Nelson M, Hedge B,  et al.  UK national guideline on safer sex advice. Int J STD AIDS. 2012;23(6):381-8. DOI: 10.1258/ijsa.2012.200312 PMID: 22807529

  5. Bignell C, Unemo M, European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.Int J STD AIDS. 2013;24(2):85-92. DOI: 10.1177/0956462412472837 PMID: 24400344

  6. Lewis DA. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.Curr Opin Infect Dis. 2014;27(1):62-7. DOI: 10.1097/QCO.0000000000000025 PMID: 24275696

  7. Brunette GW. CDC Health Information for International Travel 2014: The Yellow Book. Oxford University Press; 2013. 781 p.

  8. Abdullah ASM, Ebrahim SH, Fielding R, Morisky DE. Sexually transmitted infections in travelers: implications for prevention and control.Clin Infect Dis. 2004;39(4):533-8. DOI: 10.1086/422721 PMID: 15356817

  9. Ericsson CD, Steffen R, Matteelli A, Carosi G. Sexually transmitted diseases in travelers.Clin Infect Dis. 2001;32(7):1063-7. DOI: 10.1086/319607 PMID: 11264035

  10. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae.Clin Infect Dis. 2005;41(s4) Suppl 4;S263-8. DOI: 10.1086/430787 PMID: 16032562

  11. Behrens RH, Carroll B. The challenges of disease risk ascertainment using accessible data sources for numbers of travelers.J Travel Med. 2013;20(5):296-302. DOI: 10.1111/jtm.12062 PMID: 23992572

  12. United Nations World Tourism Organization (UNWTO). UNWTO Tourism Highlights 2014 Edition. Madrid: United Nations World Tourism Organization; 2014. Available from:

  13. European Commission. Commission Implementing Decision. 2012/506/EU of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. Communities. 3.4.2002:L 86/44. Available from:

  14. Demunter C, Dimitrakopoulou C. Tourism in Europe: Results for 2011. Eurostat; 2012. Statistics in focus. 28/2012. Available from:

  15. Eurostat. Annual data on trips of EU residents. Luxembourg: Eurostat; [Accessed 18 Aug 2015]. Available from:

  16. Mercer CH, Fenton KA, Wellings K, Copas AJ, Erens B, Johnson AM. Sex partner acquisition while overseas: results from a British national probability survey.Sex Transm Infect. 2007;83(7):517-22. DOI: 10.1136/sti.2007.026377 PMID: 17991687

  17. Danielsson M, Berglund T, Forsberg M, Larsson M, Rogala C, Tydén T. Sexual and reproductive health: Health in Sweden: The National Public Health Report 2012. Chapter 9.Scand J Public Health. 2012;40(9) Suppl;176-96. DOI: 10.1177/1403494812459600 PMID: 23238407

  18. European Centre for Disease Prevention and Control (ECDC). Thematic report: Men who have sex with men. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2014 progress report. Stockholm: ECDC. 2015. Available from:

  19. Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.PLoS Med. 2014;11(2):e1001598. DOI: 10.1371/journal.pmed.1001598 PMID: 24503544

  20. Lewis CT, de Wildt G. Sexual behaviour of backpackers who visit Koh Tao and Koh Phangan, Thailand: a cross-sectional study.Sex Transm Infect. 2016;92(6):410-4. DOI: 10.1136/sextrans-2015-052301 PMID: 27272532

  21. Kaehler N, Piyaphanee W, Kittitrakul C, Kyi YP, Adhikari B, Sibunruang S,  et al.  Sexual behavior of foreign backpackers in the Khao San Road area, Bangkok. Southeast Asian J Trop Med Public Health. 2013;44(4):690-6.PMID: 24050104

  22. Manieri M, Svensson H, Stafström M. Sex tourist risk behaviour--an on-site survey among Swedish men buying sex in Thailand.Scand J Public Health. 2013;41(4):392-7. DOI: 10.1177/1403494813480572 PMID: 23470474

  23. Bala M, Kakran M, Singh V, Sood S, Ramesh V, Members of WHO GASP SEAR Network. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.Sex Transm Infect. 2013;89(Suppl 4):iv28-35. DOI: 10.1136/sextrans-2012-050904 PMID: 24243876

  24. World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Available from:

  25. European Centre for Disease Prevention and Control (ECDC). EMIS 2010: The European Men-Who-Have-Sex-With-Men Internet Survey. Findings form 38 countries. Stockholm: ECDC; 2013. Available from:

  26. Barnett ED, MacPherson DW, Stauffer WM, Loutan L, Hatz CF, Matteelli A,  et al.  The visiting friends or relatives traveler in the 21st century: time for a new definition. J Travel Med. 2010;17(3):163-70. DOI: 10.1111/j.1708-8305.2010.00411.x PMID: 20536884

  27. Steffen R, deBernardis C, Baños A. Travel epidemiology--a global perspective.Int J Antimicrob Agents. 2003;21(2):89-95. DOI: 10.1016/S0924-8579(02)00293-5 PMID: 12615369

  28. Velicko I, Unemo M. Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011.Euro Surveill. 2012;17(29):20223.PMID: 22835468

  29. Vivancos R, Abubakar I, Hunter PR. Foreign travel, casual sex, and sexually transmitted infections: systematic review and meta-analysis.Int J Infect Dis. 2010;14(10):e842-51. DOI: 10.1016/j.ijid.2010.02.2251 PMID: 20580587

  30. Croughs M, Remmen R, Van den Ende J. The effect of pre-travel advice on sexual risk behavior abroad: a systematic review.J Travel Med. 2014;21(1):45-51. DOI: 10.1111/jtm.12084 PMID: 24354921

  31. William MR, Rollnick S. Motivational Interviewing, Second Edition: Preparing People for Change. 2nd Revised edition edition. Milwaukee, Wis.: Guilford Press; 2002. 419 p.

  32. Van Herck K, Castelli F, Zuckerman J, Nothdurft H, Van Damme P,  et al.  Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med. 2004;11(1):3-8. DOI: 10.2310/7060.2004.13609 PMID: 14769280

  33. Xiang Z, Gretzel U. Role of social media in online travel information search.Tour Manage. 2010;31(2):179-88. DOI: 10.1016/j.tourman.2009.02.016

  34. Kim H, Xiang Z, Fesenmaier DR. Use of the internet for trip planning: A generational analysis.J Travel Tour Mark. 2015;32(3):276-89. DOI: 10.1080/10548408.2014.896765

Back to Table of Contents
Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.